#USA #New York #Briya #AIRE #Jason Hein

Briya's Strategic Move: Appointing Jason Hein as CCO

Briya, the innovative developer behind the AIRE scientific AI platform, has welcomed Jason Hein as its new Chief Commercial Officer. This pivotal appointment marks the commencement of a strategic phase for Briya as it gears up to scale its operations and meet the surging demand for AI-native evidence generation in the life sciences sector. The announcement made on October 14, 2026, signifies not only a key leadership change but also highlights Briya's commitment to bridging the gap in real-world evidence generation.

Bridging the Real-World Evidence Gap

Briya's AIRE platform is designed to convert fragmented healthcare data into defensible and meaningful evidence, making it indispensable for organizations focused on research and development in life sciences. In light of increasing regulatory demands, the real-world evidence (RWE) landscape is shifting dramatically. Stakeholders, including regulators and payers, now require continuous validation of a product's real-world value. As a result, drug manufacturers find themselves in a race against time to substantiate their claims, which can be costly, with biopharma firms reportedly investing over $25 billion annually in evidence generation—primarily on expert analyses.

Chief Executive Officer David Lazerson commented on this challenge, stating that the main impediment to effective evidence generation is not a lack of scientific talent but rather the complexities introduced around that expertise. With this mindset, Briya aims to simplify these processes, making room for scientists to focus on their actual research.

Expanding Capacity with AIRE

The AIRE platform addresses operational complexities such as data preparation, harmonization, cohort building, analysis, and reporting—all while allowing researchers to maintain control over their scientific methodologies. By streamlining these processes, AIRE significantly enhances research throughput, permitting teams to achieve greater efficiency with their existing expertise. This shift is particularly valuable for Contract Research Organizations (CROs) and Health Economics and Outcomes Research (HEOR) consultancies that are under pressure to maintain high productivity and scientific quality in their offerings.

As researchers are called upon to tackle increasingly ambitious projects within stringent time frames and budgets, the technology offered by AIRE becomes crucial. The move from a labor-intensive model to a technology-driven approach is essential, especially as researchers strive to deliver valuable insights that satisfy modern market expectations.

Jason Hein's Vision and Expertise

As CCO, Jason Hein will spearhead Briya's commercial strategy worldwide. His prior experience as Director of Corporate Development at RTI International equipped him with the necessary skills to navigate the intricacies of corporate growth and strategic partnerships in the life sciences sector. In earlier roles at Codexis, he contributed to the commercialization of the ECO Synthesis® platform for nucleic acid therapeutics and at LGC Biosearch Technologies, where he further honed his expertise in corporate development.

Hein expressed enthusiasm for his new role, stating, "Research teams are being pressured to deliver more results, which can't solely be addressed by increasing personnel. Technological advancements that allow scientists to undertake more projects without compromising scientific integrity are essential. Briya AIRE is built for this purpose, and the market is poised to embrace it."

The Future of Briya and AIRE

Ultimately, AIRE is not just another research assistant; it directly interacts with patient-level data to produce accurate results from complex queries. Its capabilities include processing both structured and unstructured data, ensuring no vital information is overlooked. Moreover, it can seamlessly integrate with a multitude of data sources, from Briya's expansive network of over 120 million patient records to proprietary and third-party datasets.

As the life sciences sector evolves, Briya remains committed to enhancing research capacity and transforming the landscape of evidence generation.

For more information on Briya and its AIRE platform, visit www.briya.com.